top of page

Apple Tree Partners funds a $52M Series A for Deep Apple to leverage virtual screening

Apple Tree Partner and Deep Apple CEO Spiros Liras describes how the company aims to leverage virtual screening and machine learning to accelerate drug discovery.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page